Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...

All 16 of Indiana’s designated senior care organizations — known as Area Agencies on Aging — are now required to have a ...

Summary: A new study has identified a biomarker, DTI-ALPS, which connects glymphatic system dysfunction to vascular dementia.

A study from the Keck School of Medicine of USC has tested a biomarker linked to vascular dementia across four separate ...

A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...

January marks Alzheimer's Awareness Month - aiming to support those living with dementia. And Alzheimer Society of Manitoba CEO Erin Crawford says there is promising news when it comes to a viable ...

A University of California, Irvine-led research team has discovered intricate molecular mechanisms driving the RNA processing ...

Antibiotic use was not associated with an increased risk of cognitive impairment and dementia in healthy older adults, ...

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...